Discussion
Copper deficiency has been noted in infants of low birthweight, in malnourished babies, in infants fed with a milk formula of low copper content, in patients receiving prolonged parenteral nutrition or alkali medication for renal acidosis, or on long-term zinc therapy. All these causes could be excluded in our patient and in his family.
The face and the curly hair of the propositus suggested Menkes's syndrome. However, this inherited copper deficiency is characterised by severe neurological deterioration leading to death by 3 to 4 years, by pili torti, tortuosity of arteries, and decreased caeruloplasmin levels. None (1) Aldosterone end-organs. The membrane-bound enzyme system Na, K-ATPase, is normally stimulated by an increased sodium work load on the nephron.9 Support was therefore given to the concept of intrinsic tubular abnormality when Bierich and Schmidt found deficient Na, K-ATPase activity throughout the renal tubule in a case of PHA.4 At least distal tubular aldosterone insensitivity must be present to explain the hyperkalaemia; effects of aldosterone on the proximal tubule are controversial.6 Further evidence for end-organ resistance is given by involvement of other aldosterone targets in PHA3 and by its resistance to exogenous mineralocorticoids.1 (2) Renin-aldosterone axis. Raised aldosterone levels could be explained partly by a direct positive feedback from the end-organ or from hyperkalaemia, and partly by activation of the RA-Aldos axis in response to impaired renal perfusion.5 Excess PRA is reflected in hyperplasia of the juxtaglomerular apparatus in PHA.4 In our patient, raised plasma 17-OH progesterone and aldosterone (Table) PHA involves multiple, complex interactions between aldosterone end-organs, renal PGs, and the RA-Aldos system, creating a vicious circle. Saltwasting seems to persist in adulthood but the tendency to negative sodium balances is ameliorated by age 2 years in most cases, possibly through the combined effects of an improved salt appetite and maturation of end-organ ATP-ase function.1-4 The persistently raised PRA at 18 months in our patient illustrates that, although the clinical effects of PHA were controlled, biochemical compensation remained incomplete.
The potential toxicity of indomethacin precludes its recommendation for routine treatment of PHIA (our patient's AST levels, for example, were slightly raised) but in severe, life-threatening cases it may be a valuable adiunct to sodium supplementation.
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